Biggest News Aggregation in the World

Late Breaking Presentation Session News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Late Breaking Presentation Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Late Breaking Presentation Session Today - Breaking & Trending Today

U.S. Food and Drug Administration Grants Full Approval for BALVERSA® to Treat Locally Advanced or Metastatic Bladder Cancer with Select Genetic Alterations

Published: January 19, 2024

/PRNewswire/ -- Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for...

Source: prnewswire.com

Janssen Submits Marketing Authorisation Application to the

Published: September 8, 2023

Pending approval, erdafitinib, an investigational, once-daily oral pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor,1 will become the...

Source: globenewswire.com

Johnson & Johnson : Janssen Submits Supplemental New Drug Application to the U.S. Food and Drug Administration Seeking Full Approval of BALVERSA® (erdafitinib) for the Treatment of Patients with Locally Advanced or Metastatic Urothelial Carcinoma and Selected Fibroblast Growth Factor Receptor Gene Alterations -Today at 09:18 am

Published: August 30, 2023

News Release Media Contacts: Suzanne Frost Phone: +1 416-317-0304 Ania DiAntonio ...

Source: marketscreener.com

Janssen Announces Erdafitinib Improved Overall Survival

Published: June 5, 2023

Confirmatory data from Cohort 1 of the Phase 3 THOR study showed greater than four-month improvement in median overall survival in patients treated with...